跳至主要内容
临床试验/IRCT20180106038242N1
IRCT20180106038242N1已完成3 期

Effect of Atorvastatin in Prophylaxis of Migraine Attacks in Patients with Classic Migraine

Ahvaz University of Medical Sciences Research ?Assistance0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age 18 to 65 years
  • Having at least 3 migraine attacks per month
  • Patients who have fewer than three attacks per month, provided that they affect high-intensity attacks and the patient's life
  • Have a normal serum level of vitamin D3
  • Patients with classical migraine

排除标准

  • Patients who do not sign a form of moral consent.
  • Patients with chronic headaches (more than 15 attacks per month)
  • Patients receiving Statin for other diseases
  • Severe renal failure (GFR <30 ml / min)
  • Creatine Kinase more than 3 times normal
  • Liver enzymes more than twice the normal range
  • The increase in liver enzymes during treatment is more than 3 times the normal
  • Other patients who use drugs other than sodium valproate to treat their migraines and have their disease controlled or sodium valproate, and the disease is under control
  • Pregnant women

研究者

发起方
Ahvaz University of Medical Sciences Research ?Assistance

相似试验